Failure Pattern
DISEASE PROGRESSION, RECURRENCE, DISEASE PROGRESSION
Disease progression was observed in 180 patients. Among patients with disease progression, 108 (60.0%) had recurrence in the esophagus, 25 (13.5%) had recurrence in the regional lymph nodes, and 75 (41.4%) had recurrence in the distant lymph nodes or organs. The local-regional recurrence–free survival rates in the CRTCT group and the RT group were 62.9% vs 54.8% at 1 year, 50.3% vs 39.7% at 2 years, and 41.3% vs 29.3% at 3 years (HR, 0.75; 95% CI, 0.57-0.97; log-rank 